Refractory death rattle: Deep aspiration facilitates the effects of antisecretory agents

Journal of Pain and Symptom Management

Volumn 41, Issue 3, 2011, Pages 637-639

  Mercadante, Sebastiano ^a   Villari, Patrizia ^a   Ferrera, Patrizia ^a  

^a LA MADDALENA CANCER CENTER   (Italy)

Author keywords

anticholinergic drugs; Death rattle; end of life

Indexed keywords

DEXAMETHASONE; FUROSEMIDE; MIDAZOLAM; MORPHINE; PROPOFOL; SCOPOLAMINE BUTYL BROMIDE;

AGED; AIRWAY OBSTRUCTION; ARTICLE; CASE REPORT; CONTINUOUS INFUSION; DEATH RATTLE; DISEASE SEVERITY; DRUG DOSE INCREASE; DYSPHAGIA; DYSPNEA; FEMALE; HEALTH CARE QUALITY; HUMAN; LARYNGOSCOPY; LOW DRUG DOSE; LUNG CANCER; RELATIVE; SATISFACTION; SECRETIONS; SEDATION; TERMINAL CARE; TRACHEAL SECRETION; TRACHEOBRONCHIAL TOILET;

ADMINISTRATION, INHALATION; AGED; CHOLINERGIC ANTAGONISTS; DEATH; DYSPNEA; FATAL OUTCOME; FEMALE; HUMANS; LUNG NEOPLASMS; PAIN; PHARYNGEAL DISEASES; RESPIRATORY MECHANICS; RESPIRATORY SOUNDS; RETROSPECTIVE STUDIES; TERMINAL CARE;

EID: 79952814573     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2010.06.012     Document Type: Article

References (11)

1. Bennett MI. Death rattle: an audit of hyoscine (scopolamine) use and review of management. J Pain Symptom Manage 1996;12:229-233. (Pubitemid 26339153)
2. Wildiers H, Menten J. Death rattle: prevalence, prevention and treatment. J Pain Symptom Manage 2002;23:310-317. (Pubitemid 34462943)
3. Morita T, Tsunoda J, Inoue S, Chihara S. Risk factors for death rattle in terminally ill cancer patients: a prospective exploratory study. Palliat Med 2000;14:19-23. (Pubitemid 30095222)
4. Wee B, Coleman P, Hillier R, Holgate SH. The sound of death rattle. I: are relatives distressed by hearing this sound? Palliat Med 2006;20:169-173.
5. Wee B, Coleman P, Hillier R, Holgate SH. The sound of death rattle. II: how do relatives interpret the sound. Palliat Med 2006;20:177-181.
6. Wildiers H, Dhaenekint C, Demeulenacre P, et al. Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care. J Pain Symptom Manage 2009;38:124-133.
7. Wee B, Hillier R. Interventions for noisy breathing in patients near to death. Cochrane Database Syst Rev 2008;1:CD005177.
8. Hughes A, Wilcock A, Corcoran R, Lucas V, King A. Audit of three antimuscarinic drugs for managing retained secretions. Palliat Med 2000;14:221-222. (Pubitemid 30248552)
9. Hughel H, Ellershaw J, Gambles M. Respiratory tract secretions in the dying patient: a comparison between glycopyrronium and hyoscine hydrobromide. J Palliat Med 2006;8:279-284.
10. Back I, Jenkns K, Blower A, Beckhelling J. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle. Palliat Med 2001;15:329-336. (Pubitemid 32640551)
11. Bennett M, Lucas V, Brennan M, et al. Using anti-muscarinic drugs in the management of death rattle: evidence-based guidelines for palliative care. Palliat Med 2002;16:369-374.